SAGE is currently trading at $24.93, up 3.96 percent or $0.95 on the Nasdaq. BIIB is currently trading at $147.98 up 1.21 percent or $1.78 on the Nasdaq. The views and opinions expressed herein ...

Sage Therapeutics (NASDAQ:SAGE) has been analyzed by 14 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a ...

Sage Therapeutics, Inc. (SAGE) shares soared 35.1% in the last trading session to close at $7.50. The move was backed by solid volume with far more shares changing hands than in a normal session.

Sage Therapeutics (SAGE) said Biogen (BIIB) has made an unsolicited offer to acquire the rest of SAGE shares. Biogen currently owns a 10.2% stake in Sage Therapeutics; SAGE board members will ...

SAGE Stock Up on Biogen’s Offer Sage Therapeutics announced that its partner Biogen made an unsolicited, non-binding proposal offer to acquire the former’s shares (that it does not already own ...

SAGE-217 secured the regulatory nod in August ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

Sage Group plc has repurchased 225,151 of its ordinary shares as part of its share buyback program, with the highest price per share reaching 1,282.5 pence. The company plans to cancel all the ...

Sage Group plc announced a transaction involving the repurchase of 348,461 of its ordinary shares as part of a share buyback program. The buyback is expected to enhance shareholder value by ...

$170,000 of SAGE THERAPEUTICS lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Mental Health Innovation at large ...

Sage Group plc announced the purchase and cancellation of 46,833 ordinary shares as part of its ongoing share buyback program, which began on November 20, 2024, and is expected to conclude by June ...

Sage Group plc has repurchased 29,988 of its ordinary shares as part of a share buyback program initiated on November 20, 2024, which is set to conclude by June 3, 2025. This transaction ...